In January, Charles River Laboratories (CRL)—a major provider of biomedical products and services—announced a $510 million agreement to acquire K.F. (Cambodia) Ltd., one of its suppliers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results